Faster global financial news!
Alnylam Pharmaceuticals, Inc.
ALNY NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Jul 30, 2026
ET
EPS Est.
1.63
EPS Actual
1.21
Revenue Est.
$1.32B
Revenue Actual
$1.29B
Next Earnings Report
Date
Oct 29, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
2.19
Revenue Est.
$1.43B
Company Overview
Alnylam Pharmaceuticals, Inc. (ticker ALNY) is listed on NASDAQ with a market cap of about $31.61B. Its next earnings report (FY2026 Q3) is expected on Oct 29, 2026 (ET), Pre-market, with consensus EPS of 2.19. In the last 15 reported quarters, EPS beat consensus estimates 11 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Jul 30, 2026
Feb 23, 2023Range: -2.21 ~ 1.84Jul 30, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 30, 2026 | -- | 1.63 | Below forecast↓1.21 | $1.32B | $1.29B |
| Apr 30, 2026 | -- | 0.87 | Above forecast↑1.51 | $1.12B | $1.17B |
| Feb 12, 2026 | -- | 1.16 | Below forecast↓0.82 | $1.15B | $1.1B |
| Oct 30, 2025 | -- | 0.56 | Above forecast↑1.84 | $959.4M | $1.25B |
| Jul 31, 2025 | -- | -0.54 | -0.51 | $662.9M | $773.7M |
| May 1, 2025 | -- | -0.89 | Above forecast↑-0.44 | $585.1M | $594.2M |
| Feb 13, 2025 | -- | -0.62 | -0.65 | $582.6M | $593.2M |
| Oct 31, 2024 | -- | -0.92 | -0.87 | $532.9M | $500.9M |
| Aug 1, 2024 | -- | -1.07 | Above forecast↑-0.13 | $447.2M | $659.8M |
| May 2, 2024 | -- | -1.12 | Above forecast↑-0.52 | $428M | $494.3M |
| Feb 15, 2024 | -- | -1.20 | -1.10 | $436.9M | $439.7M |
| Nov 2, 2023 | -- | -1.34 | Above forecast↑1.15 | $396.8M | $750.5M |
| Aug 3, 2023 | -- | -1.37 | Below forecast↓-2.21 | $332.3M | $318.8M |
| May 4, 2023 | -- | -1.77 | Above forecast↑-1.40 | $312.3M | $319.3M |
| Feb 23, 2023 | -- | -1.90 | -1.68 | $313.1M | $335M |
Original Filings (SEC)
10-Q2026-07-30 ↗
8-K2026-07-30 ↗
8-K2026-05-27 ↗
10-Q2026-04-30 ↗
8-K2026-04-30 ↗
8-K2026-03-04 ↗
10-K2026-02-12 ↗
8-K2026-02-12 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
